EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibiting lncRNA NEAT1 Increases Glioblastoma Response to TMZ by Reducing Connexin 43 Expression

Jinxing Liang, Jia-Xiu Xie, Junhui He, Yi Li, Dongmei Wei, Rongfei Zhou, Guining Wei, Xuehua Liu, Qiudan Chen, Dongmei Li iD

Cancer Reports · 2024

DOI: 10.1002/cnr2.70031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Jinxing Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Research Center of Traditional Chinese Medicine and Ethnic Medicine, Guangx…. Hauptthemen laut MEDLINE: Glioblastoma, RNA, Long Noncoding, Connexin 43, Temozolomide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi Province, Specific Research Project of Guangxi for Research Bases and Talents, The Clinical Research Project of Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Glioblastoma multiforme (GBM) is considered the most assailant subtype of gliomas, presenting a formidable obstacle because of its inherent resistance to temozolomide (TMZ). This study aimed to characterize the function of lncRNA NEAT1 in facilitating the advancement of gliomas.

Methods

The expression level of NEAT1 in glioma tissues and cells was detected by qRT‐PCR. RNA interference experiment, cell proliferation assay, FITC/PI detection assay, immunoblotting, bioinformatics prediction, a double luciferase reporter gene assay, RNA immunoprecipitation (RIP) assay, SLDT assay and correlation analysis of clinical samples were performed to explore the regulatory effects of NEAT1, miR‐454‐3p and Cx43 and their role in malignant progression of GBM. The role of NEAT1 in vivo was investigated by an intracranial tumor formation experiment in mice.

Results

The results showed that recurring gliomas displayed elevated levels of NEAT1 compared to primary gliomas. The suppression of NEAT1 led to a restoration of sensitivity in GBM cells to TMZ. NEAT1 functioned as a competitive endogenous RNA against miR‐454‐3p. Connexin 43 was identified as a miR‐454‐3p target. NEAT1 was found to regulate gap junctional intercellular communication by modulating Connexin 43, thereby impacting the response of GBM cells to TMZ chemotherapy. Downregulation of NEAT1 resulted in enhanced chemosensitivity to TMZ and extended the survival of mice.

Conclusions

Overall, these results indicated that the NEAT1/miR‐454‐3p/Connexin 43 pathway influences GBM cell response to TMZ and could offer a potential new strategy for treating GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaRNA, Long NoncodingConnexin 43TemozolomideMicroRNAsGene Expression Regulation, NeoplasticBrain NeoplasmsCell ProliferationHumansAnimalsMiceDrug Resistance, NeoplasmCell Line, TumorXenograft Model Antitumor AssaysAntineoplastic Agents, AlkylatingMaleFemale

Stichwörter der Autor:innen

Connexin 43NEAT1chemotherapy sensitivitymiR‐454‐3ptemozolomide

Substanzen

RNA, Long NoncodingConnexin 43TemozolomideNEAT1 long non-coding RNA, humanMicroRNAsGJA1 protein, humanMIRN454 microRNA, humanAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Research Center of Traditional Chinese Medicine and Ethnic Medicine, Guangxi Institute of Chinese Medicine and Pharmaceutical Science, Nanning, C…
  • Pharmaceutical College, Guangxi Medical University, Nanning, China.
  • Department of Cardiology, Sir Run Run Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Clinical Laboratory, Central Laboratory, Jing'an District Center Hospital of Shanghai, Fudan University, Shanghai, China.
  • School of Chemistry & Pharmaceutical Sciences, State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, Guilin, China.

ORCID-Profile: Dongmei Li

Förderung

  • Natural Science Foundation of Guangxi Province
  • Specific Research Project of Guangxi for Research Bases and Talents
  • The Clinical Research Project of Shanghai Municipal Health Commission
  • Guangxi traditional Chinese medicine key discipline construction project
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Liang, J., Xie, J. X., He, J., Li, Y., Wei, D., Zhou, R., Wei, G., Liu, X., Chen, Q., & Li, D. (2024). Inhibiting lncRNA NEAT1 Increases Glioblastoma Response to TMZ by Reducing Connexin 43 Expression. Cancer Reports. https://doi.org/10.1002/cnr2.70031

Vancouver

Liang J, Xie JX, He J, Li Y, Wei D, Zhou R, et al. Inhibiting lncRNA NEAT1 Increases Glioblastoma Response to TMZ by Reducing Connexin 43 Expression. Cancer Reports. 2024. doi:10.1002/cnr2.70031

BibTeX
@article{Liang2024,
  author = {Liang, Jinxing and Xie, Jia-Xiu and He, Junhui and Li, Yi and Wei, Dongmei and Zhou, Rongfei and Wei, Guining and Liu, Xuehua and Chen, Qiudan and Li, Dongmei},
  title = {Inhibiting lncRNA NEAT1 Increases Glioblastoma Response to TMZ by Reducing Connexin 43 Expression},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.70031}
}
Kostenlos starten →